Actavis brokered deal to maintain high hydrocortisone prices

A government watchdog has alleged that manufacturers Actavis UK and Concordia worked together to artificially maintain an inflated price for hydrocortisone tablets.

actavis_logo_620x413px.jpg
Actavis UK remained sole supplier of hydrocortisone tablets until 2015

According to a Competition and Markets Authority (CMA) investigation, between January 2013 and June 2016 the two companies agreed that Concordia (formerly Amdipharm) would not enter the market with its own version of hydrocortisone tablets.

Free to registered users

Register to gain full access to C+D and C+D Community content

Sign in or register for free

Latest from News

BREAKING: Pharmacies to cut hours and services from April 1

 
• By 
 • comment0

The National Pharmacy Association (NPA) has announced that it is advising its 6,000 member pharmacies to limit services and reduce opening hours in protest against “unsustainable” funding.

Sebco coal tar scalp ointment appointed by DHSC to support current shortages

 • comment1

Due to shortages in coal tar scalp ointment, the DHSC has asked the manufacturer of an equivalent product - Sebco - to provide increased stock levels to support patients during this time.

Pharmacies to boost naloxone stock amid ‘sudden’ overdose spike

 
• By 
 • comment0

Pharmacies in Scotland have been asked to ensure they have the “appropriate stock” of naloxone – a medicine used to reverse the effects of an opiate overdose – following an “increase in sudden collapse” due to overdoses.

More from Regulation

Pharmacist warned after sending patient ‘unsolicited’ message on social media

 
• By 
 • comment

A pharmacist has been issued a warning after accessing a patient’s contact details from medical records and sending them an “unsolicited” message on social media.

‘Urgent review’ of epilepsy medicine shortages needed, say group of MPs

 
• By 
 • comment

A group of 45 cross-party MPs have signed a letter to Wes Streeting calling for “an urgent review into ongoing medication shortages”, saying that if action is not taken, the crisis will “worsen”.